Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Preclinical studies reported for rizatriptan

June 19, 1997

Almotriptan: a novel antimigraine agent from Almirall

June 19, 1997

Preclinical profile of novel migraine abortive from BMS

June 19, 1997

Targets for antimigraine therapy: antiepileptic drugs in the treatment of migraine

June 19, 1997

LMW inhibitor of Tat-TAR interaction and HIV replication prepared at Novartis

June 18, 1997

Dainippon Ink presents new antiallergic/antiasthmatic agent

June 18, 1997

Novel CCK-B antagonist with anxiolytic activity from Rotta

June 18, 1997

High-dose riboflavin for migraine prophylaxis

June 18, 1997

Targets for antimigraine therapy: SSRIs in the prevention of migraine

June 18, 1997

Targets for antimigraine therapy: NOS inhibitors as new therapeutic approach

June 18, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...